Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

LIVE: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in:

Open Access 01-12-2017 | Research article

Amino acid profiling in the gestational diabetes mellitus

Authors: Najmeh Rahimi, Farideh Razi, Ensieh Nasli-Esfahani, Mostafa Qorbani, Nooshin Shirzad, Bagher Larijani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2017

Login to get access

Abstract

Background

The prevalence of gestational diabetes mellitus (GDM) is increasing globally which is associated with various side effects for mothers and fetus. It seems that metabolomic profiling of the amino acids may be useful in early diagnosis of metabolic diseases. This study aimed to explore the association of the amino acids profiles with GDM.

Methods

Eighty three pregnant women with gestational age ≥25 weeks were randomly selected among pregnant women referred to prenatal care clinic in Arash hospital of Tehran, Iran. Women divided into three groups including 1) 25 pregnant women with normal glucose tolerance test, 2) 27 pregnant women with diabetes type 2 (T2D) (n: 27) and 3) 31 women with GDM (n: 31). Plasma levels of amino acids were measured by high performance liquid chromatography and were compared in three groups. Statistical analysis was performed using SPSS 16.

Results

Compared with normal mothers, GDM mothers showed higher plasma concentrations of Arginine (P = 0.01), Glycine (P = 0.01) and Methionine (P = 0.04), whereas the pregnant women with T2D had higher plasma levels of Asparagine (P = 0.01), Tyrosine (P < 0.01), Valine (P < 0.01), Phenylalanine (P < 0.01), Glutamine (P < 0.01) and Isolucine (P < 0.01). The results of regression analyses confirmed the significantly elevated in plasma concentration of Asparagine (OR:3.64, CI 1.22–10.47), Threonine (OR:3.38, CI 1.39–8.25), Aspartic acid (OR:3.92, CI 1.19–12.91), Phenylalanine (OR:2.66, CI 1.01–6.94), Glutamine (OR:2.53, CI 1.02–6.26) and Arginine (OR:1.96, CI 1.02–3.76) after adjustment for gestational age and BMI in GDM mothers compared to normal ones.

Conclusions

Amino acids levels are associated with risk of GDM and diabetes mellitus. However further prospective studies are needed to clarify the role of different metabolites involved in mechanism of GDM.
Literature
1.
Kim C. Gestational diabetes: risks, management, and treatment options. Int J Women’s health. 2010;2:339–51.CrossRef
2.
Nezami N, Safa J, Eftekhar-Sadat AT, Salari B, Ghorashi S, Sakhaee K, et al. Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. Clin Biochem. 2010;43(16–17):1294–9.CrossRefPubMed
3.
Association AD. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Supplement 1):S8–S16.CrossRef
4.
Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S. Gestational diabetes mellitus--guidelines. J Assoc Physicians India. 2006;54:622–8.PubMed
5.
Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B. Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health. 2014;43(6):713–21.PubMedPubMedCentral
6.
Alavinia M, Etemad K, A M. Gestational diabetes mellitus in Iran- experience from the national diabetes program. Int J Pharm Healthc Mark. 2007;6(2):156–66.
7.
Hossein-Nezhad A, Maghbooli Z, Vassigh AR, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwanese J Obstet Gynecol. 2007;46(3):236–41.CrossRefPubMed
8.
Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and Risk Factors of Gestational Diabetes in Iran: A Systematic Review and Meta-Analysis. Iran J Public Health. 2015;44(8):1036–44.PubMedPubMedCentral
9.
Cabrera PA, Lloyd S, Haran G, Pineyro L, Parietti S, Gemmell MA, et al. Control of Echinococcus granulosus in Uruguay: evaluation of different treatment intervals for dogs. Vet Parasitol. 2002;103(4):333–40.CrossRefPubMed
10.
Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192(4):989–97.CrossRefPubMed
11.
Agarwal MM, Boulvain M, Coetzee E, Colagiuri S, Falavigna M, Hod M, et al. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A world health organization guideline. Diabetes Res Clin Pract. 2014;103:341–63.CrossRef
12.
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448–53.CrossRefPubMedPubMedCentral
13.
Hajduk J, Klupczynska A, Derezinski P, Matysiak J, Kokot P, Nowak DM, et al. A Combined Metabolomic and Proteomic Analysis of Gestational Diabetes Mellitus. Int J Mol Sci. 2015;16(12):30034–45.CrossRefPubMedPubMedCentral
14.
Bentley-Lewis R, Xiong G, Lee H, Yang A, Huynh J, Kim C. Metabolomic Analysis Reveals Amino Acid Responses to an Oral Glucose Tolerance Test in Women with Prior History of Gestational Diabetes Mellitus. J Clin Transl Endocrinol. 2014;1(2):38–43.CrossRefPubMedPubMedCentral
15.
Beigi A, Shirzad N, Nikpour F, Nasli Esfahani E, Emamgholipour S, Bandarian F. Association between serum adropin levels and gestational diabetes mellitus; a case–control study. Gynecol Endocrinol. 2015;31(12):939–41.CrossRefPubMed
16.
Bentley-Lewis R, Huynh J, Xiong G, Lee H, Wenger J, Clish C, et al. Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia. 2015;58(6):1329–32.
17.
Cetin I, de Santis MS, Taricco E, Radaelli T, Teng C, Ronzoni S, et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol. 2005;192(2):610–7.CrossRefPubMed
18.
19.
Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–48.CrossRefPubMedPubMedCentral
20.
Irving BA, Carter RE, Soop M, Weymiller A, Syed H, Karakelides H, et al. Effect of insulin sensitizer therapy on amino acids and their metabolites. Metabolism. 2015;64(6):720–8.CrossRefPubMedPubMedCentral
21.
Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014;2(1):65–75.CrossRefPubMed
22.
23.
Metzger BE, Phelps RL, Freinkel N, Navickas IA. Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care. 1980;3(3):402–9.CrossRefPubMed
24.
Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL. Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol. 2007;196(4):410. e1–. e7.
25.
She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol-Endocrinol Metabol. 2007;293(6):E1552–63.CrossRef
26.
Würtz P, Soininen P, Kangas AJ, Rönnemaa T, Lehtimäki T, Kähönen M, et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care. 2013;36(3):648–55.CrossRefPubMedPubMedCentral
27.
Butte NF, Hsu HW, Thotathuchery M, Wong WW, Khoury J, Reeds P. Protein metabolism in insulin-treated gestational diabetes. Diabetes Care. 1999;22(5):806–11.CrossRefPubMed
28.
Pappa KI, Vlachos G, Theodora M, Roubelaki M, Angelidou K, Antsaklis A. Intermediate metabolism in association with the amino acid profile during the third trimester of normal pregnancy and diet-controlled gestational diabetes. Am J Obstet Gynecol. 2007;196(1):65.e1–.e5.
29.
Scholtens DM, Muehlbauer MJ, Daya NR, Stevens RD, Dyer AR, Lowe LP, et al. Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care. 2014;37(1):158–66.CrossRefPubMed
30.
Kalhan SC. Protein metabolism in pregnancy. In: Cowett RM, ed. Principles of perinatal-neonatal metabolism. 2nd ed. New York: Springer; 1998. p. 207–20.
31.
Park S, Park JY, Lee JH, Kim SH. Plasma levels of lysine, tyrosine, and valine during pregnancy are independent risk factors of insulin resistance and gestational diabetes. Metab Syndr Relat Disord. 2015;13(2):64–70.CrossRefPubMed
32.
Metadata
Title
Amino acid profiling in the gestational diabetes mellitus
Authors
Najmeh Rahimi
Farideh Razi
Ensieh Nasli-Esfahani
Mostafa Qorbani
Nooshin Shirzad
Bagher Larijani
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2017
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-016-0283-1

Other articles of this Issue 1/2017

Perceived cognitive deficits are associated with diabetes self-management in a multiethnic sample

  • Open Access
  • Research article

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study

  • Open Access
  • Research article

Prevalence of metabolic syndrome and health-related quality of life in war-related bilateral lower limb amputees

  • Open Access
  • Research article

Associations of MTHFR C677T polymorphism with insulin resistance, results of NURSE Study (Nursing Unacquainted Related Stress Etiologies)

  • Open Access
  • Research article

Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats

  • Open Access
  • Research article

Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia

  • Open Access
  • Research article

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits